Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Piotr Trzonkowsk

Market Cap

255.56 Million PLN

Sector

Healthcare

Website

https://poltreg.tech

Description

Poltreg S.A.

Read More

Overview

Value

1

Growth

23

Health

60

Management

39

Analyst Opinion

69

Total

38

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Has strong financial health
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth
  • Accounting anomalies: Growing revenues without a corresponding growth in cash flows.

Market Peers

PTG.WA

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-90.77%

Revenue Growth (5 Year Average)

11.70%

Ratings Consensus

Buy

Share Buybacks

-0.83%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of 5.04 PLN is lower than current price ( 54.80 PLN)
  • Free-cashflow-yeild of -3.99% is worse than the market average (4.7%)
  • Margin-of-safety of -90.77% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 13.1 PLN

Current Price: 54.6 PLN

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-3.99%

PE/Earnings Growth

N/A

Price/Book

2.51x

Growth

Growth Score

23

  • 5 Year Average Revenue growth of 11.70% is higher than the market average (10.97%)
  • Revenue growth has improved this yeara
  • 5 Year Average Earnings growth of 13.44% is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -22.32% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

11.70%

Earnings Growth

13.44%

Cashflow Growth

-22.32%

Health

Health Score

60

  • Has a low level of debt
  • Assets cover liabilities
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

0.00x

Current Assets/Liabilities

18.65x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.00x

Management

Management Score

39

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of -2.22% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -4.93% is lower than the market average (15%)

Average Buybacks/Dilution

-0.83%

Recent Buybacks/Dilution

36.56%

5 Year Price Volitility

8.74%

Return On Assets

-4.66%

Return On Capital Employed

-2.22%

Return On Equity

-4.93%

Return On Free Cashflow

182.32%

Return On Investments

N/A

Analysts

Analyst Opinion

69

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Poltreg S.A.

Currency

PLN

Beta

0

Vol Avg

1502

Ceo

Mr. Piotr Trzonkowsk

Cik

Cusip

Exchange

Warsaw Stock Exchange

Full Time Employees

11

Industry

Biotechnology

Sector

Healthcare

Ipo Date

Address

Waly Piastowskie 1 lok. 1508

City

Gdansk

State

Country

PL

Zip

80-855

Phone

48 512 53 24 01

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies